Amylyx Pharmaceuticals Announces Presentation of New Analysis of CENTAUR Trial Results at the European Network to Cure ALS 2022 Meeting

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx announces poster presentation at the European Network to Cure ALS (ENCALS) 2022 Meeting on June 2, 2022 in Edinburgh, Scotland.
Click here to view original post